At the time of writing, Ekso Bionics Holdings Inc [EKSO] stock is trading at $4.53, down -0.23%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The EKSO shares have gain 8.40% over the last week, with a monthly amount drifted -36.29%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
For the past year, the stock price of Ekso Bionics Holdings Inc fluctuated between $0.23 and $1.53. Currently, Wall Street analysts expect the stock to reach $1 within the next 12 months. Ekso Bionics Holdings Inc [NASDAQ: EKSO] shares were valued at $4.53 at the most recent close of the market. An investor can expect a potential drop of -77.92% based on the average EKSO price forecast.
Analyzing the EKSO fundamentals
According to Ekso Bionics Holdings Inc [NASDAQ:EKSO], the company’s sales were 17.54M for trailing twelve months, which represents an -10.14% plunge. Gross Profit Margin for this corporation currently stands at 0.53% with Operating Profit Margin at -0.61%, Pretax Profit Margin comes in at -0.62%, and Net Profit Margin reading is -0.62%. To continue investigating profitability, this company’s Return on Assets is posted at -0.4, Equity is -0.82 and Total Capital is -0.57. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.44.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.2871 points at the first support level, and at 0.2722 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.3098, and for the 2nd resistance point, it is at 0.3176.
Ratios To Look Out For
It is important to note that Ekso Bionics Holdings Inc [NASDAQ:EKSO] has a current ratio of 2.35. Further, the Quick Ratio stands at 1.77. Considering the valuation of this stock, the price to sales ratio is 9.12, the price to book ratio is 10.06.
